U.K. Regulators To Consider FDA-Style Transparency
Executive Summary
The U.K.' s Medicines Control Agency will consider the adoption of FDA-style transparency to communicate information about its activities more effectively, according to a five-year review of the agency conducted by the U.K. Department of Health.